Mauro Di Matteo Selected Research

prolinamide

5/2018

Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mauro Di Matteo Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016 - 01/2016
1	Glioma (Gliomas) 05/2018
1	Cognitive Dysfunction 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Intellectual Disability (Idiocy) 01/2016

Drug/Important Bio-Agent (IBA)

1	Biological ProductsIBA 05/2018
1	prolinamideIBA 05/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Aromatase InhibitorsIBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Hormones (Hormone)IBA 01/2016

Therapy/Procedure

1	Therapeutics 05/2018